Relationship between undetectable PSA nadir and outcomes for patients with metastatic hormone-sensitive prostate cancer (mHSPC) in IRONMAN, the International Registry for Men with Advanced Prostate Cancer Meeting Abstract

  

Authors:	McManus, H. D.; Howard, L.; Crowell, K. A.; Hyslop, T.; Autio, K. A.; Rathkopf, D.; Dreicer, R.; Chi, K. N.; Ong, M.; Mateo, J.; Enting, D.; Esteban, E.; Khoo, V.; McMannis, A.; Green, R.; Pileggi, S.; Vinson, J.; Kantoff, P. W.; Mucci, L. A.; George, D. J.
Abstract Title:	Relationship between undetectable PSA nadir and outcomes for patients with metastatic hormone-sensitive prostate cancer (mHSPC) in IRONMAN, the International Registry for Men with Advanced Prostate Cancer
Meeting Title:	2025 ASCO Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	43
Issue:	5 Suppl.
Meeting Dates:	2025 Feb 13-15
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2025-02-10
Language:	English
ACCESSION:	WOS:001454744600040
DOI:	10.1200/JCO.2025.43.5_suppl.65
PROVIDER:	wos
Notes:	Meeting Abstract: 65 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/225303